Literature DB >> 2797425

Sex and age related differences in postmyelographic adverse reactions. A prospective study of 1765 myelographies.

P Maly1.   

Abstract

Differences in frequency of postmyelographic adverse reactions were analyzed with respect to sex and age in a prospective study including 1026 patients injected with metrizamide and 739 injected with iohexol. Regardless of the type of contrast medium or myelography, all types of adverse reactions were 1.4-3.8 times as frequent in women as in men. Most of the differences were statistically significant. Headache was more frequent, while vomiting and dizziness were less frequent in both women and men aged 26-50 years compared with those over 50 years of age. Dizziness and increased low back pain were consistently reported spontaneously by the patients less frequently than emerged via formal interview. The large differences between the sexes suggest that further research on contrast media toxicity would be best performed with separation of the data by gender.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2797425     DOI: 10.1007/bf00344177

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  11 in total

1.  Lumbar radiculography with metrizamide. A nonionic water-soluble contrast medium.

Authors:  I O Skalpe; P Amundsen
Journal:  Radiology       Date:  1975-04       Impact factor: 11.105

2.  Thoracic and cervical myelography with metrizamide. Clinical experiences with a water-soluble, non-ionic contrast medium.

Authors:  I O Skalpe; P Amundsen
Journal:  Radiology       Date:  1975-07       Impact factor: 11.105

3.  Lumbar myelography with Conray Meglumin 282. Report of 100 investigations with special reference to the adverse effects.

Authors:  I O Skalpe
Journal:  Acta Neurol Scand       Date:  1971       Impact factor: 3.209

4.  A randomized, double-blind clinical trial comparing the 22 versus 26 gauge needle in the production of the post-lumbar puncture syndrome in normal individuals.

Authors:  W W Tourtellotte; W G Henderson; R P Tucker; O Gilland; J E Walker; E Kokman
Journal:  Headache       Date:  1972-07       Impact factor: 5.887

5.  Cervical myelography with iopamidolo.

Authors:  G Belloni; G Bonaldi; L Moschini; N Quilici
Journal:  Neuroradiology       Date:  1981-03       Impact factor: 2.804

6.  Relationship between contrast medium dose and adverse effects in lumbar myelography.

Authors:  J T Wilmink; S F Lindeboom; L M Vencken; W vd Burg
Journal:  Diagn Imaging Clin Med       Date:  1984

7.  Iohexol: summary of North American and European clinical trials in adult lumbar, thoracic, and cervical myelography with a new nonionic contrast medium.

Authors:  D D Shaw; T Bach-Gansmo; K Dahlstrom
Journal:  Invest Radiol       Date:  1985 Jan-Feb       Impact factor: 6.016

8.  Iohexol vs. metrizamide: study of efficacy and morbidity in cervical myelography.

Authors:  R E Latchaw; W L Hirsch; J A Horton; D Bissonette; D D Shaw
Journal:  AJNR Am J Neuroradiol       Date:  1985 Nov-Dec       Impact factor: 3.825

9.  Myelography with iohexol (Omnipaque); a clinical report with special reference to the adverse effects.

Authors:  I O Skalpe; P Nakstad
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

10.  Iohexol compared to metrizamide in cervical and thoracic myelography. A randomized double blind parallel study.

Authors:  P Nakstad; A Helgetveit; O Aaserud; T Ganes; R Nyberg-Hansen
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

View more
  1 in total

1.  Laryngeal edema, following the injection of iohexol into the subarachnoid space.

Authors:  A M Agìldere; M Halìloglu; A Cìla; M Ozmen
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.